By Deron Hamel The Ontario government is asking for input from people who have had experience living with uncontrolled focal onset seizures for an upcoming assessment of a new anti-seizure drug. An expert committee, established by the province to review medications, will assess this input along with clinical trial data and an economic evaluation of…
By Deron Hamel Epilepsy Ontario is urging people taking 250-mg soft-gel capsules of the anti-seizure medication Zarontin (ethosuximide) to closely scrutinize their capsules to ensure they are not defective, following a warning issued by Erfa Canada 2012 Inc. and Health Canada. Erfa Canada 2012 Inc., the company that manufactures Zarontin, and Health Canada have received…
By Deron Hamel Epilepsy Ontario announced today that it has entered a partnership with EpLink to fund a study to research the link between brain trauma and the development of epilepsy. There is a body of evidence that shows people who suffer brain trauma are at increased risk of developing epilepsy. What is not known…
By Deron Hamel Epilepsy Ontario is working on a project to create an information package epilepsy support agencies across the province can use to educate police services and first responders on how to identify people who are having a non-convulsive seizure. The provincial agency is adapting a project created by Epilepsy Toronto to help build…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
